Dr. Kelsey Natsuhara, current UCSF IM resident, is lead author on a new study "Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma" in the Journal of Onco-Nephrology. She is co-mentored by our Dr. Christopher Carlos.
Dr. Kelsey Natsuhara, current UCSF IM resident, is lead author on a new study "Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma" in the Journal of Onco-Nephrology. She is co-mentored by our Dr. Christopher Carlos.
